Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
01/09/2014 | US20140008264 Biodegradable Natural Films Based on Co-Products Derived from Industrial-Scale Seed-Treatment Processes |
01/08/2014 | EP2682128A1 Medicinal agent for inhibiting metastasis of malignant tumor |
01/08/2014 | EP2682114A1 Milnacipran for the long-term treatment of fibromyalgia syndrome |
01/08/2014 | EP2682111A1 Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
01/08/2014 | EP2680858A1 Proteasome inhibitor delanzomib for use in the treatment of lupus |
01/08/2014 | EP2680841A1 Use of glycopyrrolate for treating tachycardia |
01/08/2014 | EP2680821A2 Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it |
01/08/2014 | CN103501800A Beautiful-skin-promoting agent and use thereof |
01/08/2014 | CN103501785A Csf-1r inhibitors for treatment of brain tumors |
01/08/2014 | CN103501781A Use of glycopyrrolate for treating tachycardia |
01/08/2014 | CN103501772A Composition comprising diindolylmethane and retinoid to treat skin condition |
01/08/2014 | CN103495179A Polymer albumin nanosphere as well as preparation method and applications of nanosphere |
01/08/2014 | CN103495174A Multi-effect external preparation used for treating superficial skin injury and application thereof |
01/08/2014 | CN103495173A Trauma therapy |
01/08/2014 | CN103495172A Medicament for treating amphetamine type stimulant dependency and mixed dependency of amphetamine type stimulants and opiates substances |
01/08/2014 | CN103495171A Pharmaceutical and cosmetic formulations for treating fingernails |
01/08/2014 | CN103495170A Method of reducing multi-drug resistance using inositol tripyrophosphate |
01/08/2014 | CN103495169A Methods and compositions for treatment and control of multiple myeloma |
01/08/2014 | CN103494817A Methods and compoistions used for treatment and control of multiple myeloma |
01/08/2014 | CN103494765A Porous silicon drug-eluting particles |
01/08/2014 | CN103493799A Improved organ protection, preservation and recovery |
01/08/2014 | CN102772424B Application of neohesperidin in preparing of diabetes preventive treatment medicines |
01/08/2014 | CN102688223B Anti-cancer drug-loading nanofiber film and preparation method thereof |
01/08/2014 | CN101932939B Marker for determination of sensitivity to anti-cancer agent |
01/08/2014 | CN101547698B Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses |
01/07/2014 | US8623874 Method of treating neurodegenerative diseases |
01/07/2014 | US8623864 Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance |
01/07/2014 | US8623857 N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1 |
01/07/2014 | US8623851 Formoterol/steroid bronchodilating compositions and methods of use thereof |
01/07/2014 | US8623847 Compositions for treatment of inflammatory diseases |
01/07/2014 | US8623833 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
01/07/2014 | US8623819 Therapy for complications of diabetes |
01/07/2014 | US8623422 Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions |
01/07/2014 | US8623393 Biomatrix structural containment and fixation systems and methods of use thereof |
01/07/2014 | US8623384 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of acute myelogenous leukemia |
01/07/2014 | US8623349 Systems, methods and microrganisms for antibody production with type III secretion system |
01/07/2014 | CA2664915C Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
01/07/2014 | CA2594187C Method for producing probiotically derived compounds |
01/07/2014 | CA2461372C Dna sequences for human angiogenesis genes |
01/07/2014 | CA2286798C Alpha-o-linked glycoconjugates with clustered(2,6)-st epitopes, methods of preparation and uses thereof |
01/03/2014 | WO2014004902A2 Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof |
01/03/2014 | WO2014004674A2 Methods for treating hcv |
01/03/2014 | WO2014004470A1 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors |
01/03/2014 | WO2014003155A1 Pharmaceutical composition containing compound having thrombopoietin receptor agonistic activity |
01/03/2014 | WO2014003116A1 Nutritional composition |
01/03/2014 | WO2014001882A1 Composition comprising a sesterterpene and use thereof as antibiotic and antifungal adjuvant |
01/03/2014 | WO2014001314A1 Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders |
01/03/2014 | CA2877874A1 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors |
01/03/2014 | CA2876496A1 Methods for treating hcv |
01/02/2014 | US20140007292 Novel Insecticidal Proteins and Methods for Their Use |
01/02/2014 | US20140005262 Racecadotril lipid compostions |
01/02/2014 | US20140005261 Racecadotril liquid compositions |
01/02/2014 | US20140005256 Formulations with anti-tumour action |
01/02/2014 | US20140005255 Agonists Of Toll Like Receptor For Treating Cardiovasuclar Disease And Obesity |
01/02/2014 | US20140005249 Nkx2.2 inhibitors as drugs |
01/02/2014 | US20140005226 Phenoxyethyl piperidine compounds |
01/02/2014 | US20140005225 Method of inhibiting c-kit kinase |
01/02/2014 | US20140005215 Selective Opioid Compounds |
01/02/2014 | US20140005211 Derivatives of pyrazole-substituted amino-heteroaryl compounds |
01/02/2014 | US20140005199 Implant for the controlled release of pharmaceutically active agents |
01/02/2014 | US20140005192 Inhibitors of influenza viruses replication |
01/02/2014 | US20140005178 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
01/02/2014 | US20140005177 Pyridinyl- and pyrazinyl-methyloxy-aryl derivatives useful as inhibitors of spleen tyrosine kinase (syk) |
01/02/2014 | US20140005168 5-azaindazole compounds and methods of use |
01/02/2014 | US20140005155 Organic compounds |
01/02/2014 | US20140005154 6,7-Dihydrothieno[3,2-d]pyrimidine for the Treatment of Inflammatory Diseases |
01/02/2014 | US20140005151 Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof |
01/02/2014 | US20140005150 3,4-diarylpyrazoles as protein kinase inhibitors |
01/02/2014 | US20140005139 Cellooligosaccharide-containing composition |
01/02/2014 | US20140005136 Novel compounds and compositions and methods of use |
01/02/2014 | US20140005122 Gemcitabine combination therapy |
01/02/2014 | US20140005111 Injectable delivery system for heparan-binding growth factors |
01/02/2014 | US20140005108 Method for decreasing low density lipoprotein levels |
01/02/2014 | US20140005104 Polyheterocyclic compounds highly potent as hcv inhibitors |
01/02/2014 | US20140005096 Methods of treating inflammation |
01/02/2014 | US20140004199 Drug carrier for tumor-targeted therapy, its preparation method and its use |
01/02/2014 | US20140004192 Pharmaceutical formulations of indibulin and uses thereof |
01/02/2014 | US20140004190 Solid Dosage Forms of Bendamustine |
01/02/2014 | US20140004181 Compositions and methods for exosome targeted expression |
01/02/2014 | US20140004175 Angiopoietin derived peptides |
01/02/2014 | US20140004174 Selective inhibitors of histone deacetylase |
01/02/2014 | US20140004151 Antigens and Epitopes Derived From Mycobacterium Tuberculosis |
01/02/2014 | US20140004124 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma |
01/02/2014 | US20140004119 Agonistic antibodies to trkc receptors and uses thereof |
01/02/2014 | US20140004118 Clostridium difficile antibodies |
01/02/2014 | US20140004116 Methods of preventing or treating pain using anti-ngf antibodies |
01/02/2014 | US20140004115 Methods of preventing or treating pain using anti-ngf antibodies that selectively inhibit the association of ngf with trka, without affecting the association of ngf with p75 |
01/02/2014 | US20140004112 Therapeutic Peptides |
01/02/2014 | US20140004110 Anti cd37 antibodies |
01/02/2014 | US20140004104 Combination therapy of a type ii anti-cd20 antibody with an anti-bcl-2 active agent |
01/02/2014 | US20140004101 Smac peptidometics useful as iap inhibitors |
01/02/2014 | US20140004100 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
01/02/2014 | US20140004082 Methods for treating leukemia and disorders mediated by cbfbeta and runx1 proteins |
01/02/2014 | US20140004081 Re-Directed Immunotherapy |
01/02/2014 | US20140004078 Immunoconjugates with an Intracellularly-Cleavable Linkage |
01/02/2014 | US20140004077 Method for treating cervical cancer |
01/02/2014 | US20140004038 Combinatorial therapy |
01/01/2014 | EP2679230A1 Pharmaceutical formulation comprising compounds of the jasmonate family |
01/01/2014 | EP2679224A1 Nitro oleic acid modulation of type II diabetes |
01/01/2014 | EP2679223A1 Treatments using citrulline |